Cargando…

RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity

Ribosomal S6 kinase 2 (RSK2), regulated by Ras/Raf/MEKs/ERKs, transmits upstream activation signals to downstream substrates including kinases and transcription and epigenetic factors. We observed that ELK members, including ELK1, 3, and 4, highly interacted with RSK2. We further observed that the R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Sun-Mi, Lee, Cheol-Jung, An, Hyun-Jung, Lee, Joo Young, Lee, Hye Suk, Kang, Han Chang, Cho, Sung-Jun, Kim, Seung-Min, Park, Juhee, Kim, Dae Joon, Cho, Yong-Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515335/ https://www.ncbi.nlm.nih.gov/pubmed/31018569 http://dx.doi.org/10.3390/ijms20081994

Ejemplares similares

Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway
por: Lee, Cheol-Jung, et al.
Publicado: (2015)

RSK-c-Fos in KSHV lytic progression
por: Li, Xiaojuan, et al.
Publicado: (2015)

Fargesin Inhibits EGF-Induced Cell Transformation and Colon Cancer Cell Growth by Suppression of CDK2/Cyclin E Signaling Pathway
por: Lee, Ga-Eun, et al.
Publicado: (2021)

FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation
por: Lee, Cheol-Jung, et al.
Publicado: (2020)

Genome-Wide Analysis Reveals PADI4 Cooperates with Elk-1 to Activate c-Fos Expression in Breast Cancer Cells
por: Zhang, Xuesen, et al.
Publicado: (2011)

Molecular Targeting of ERKs/RSK2 Signaling Axis in Cancer Prevention
por: Yoo, Sun-Mi, et al.
Publicado: (2015)

ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer
por: Jung, Hae-Yun, et al.
Publicado: (2023)

Differential activation of c-Fos in the paraventricular nuclei of the hypothalamus and thalamus following myocardial infarction in rats
por: Tae, Hyun-Jin, et al.
Publicado: (2016)

EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling
por: Linder, Markus, et al.
Publicado: (2018)

HPV-18 E7 Interacts with Elk-1 Leading to Elevation of the Transcriptional Activity of Elk-1 in Cervical Cancer
por: Go, Sung-Ho, et al.
Publicado: (2022)

C/EBPBeta and Elk-1 synergistically transactivate the c-fos serum response element
por: Hanlon, Mary, et al.
Publicado: (2000)

ELK3 Controls Gastric Cancer Cell Migration and Invasion by Regulating ECM Remodeling-Related Genes
por: Lee, Minwook, et al.
Publicado: (2022)

Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells
por: Song, Ji‐Hong, et al.
Publicado: (2018)

ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
por: Park, Joo Dong, et al.
Publicado: (2022)

Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition
por: Li, Tian Zhu, et al.
Publicado: (2017)

Cyclin dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway
por: Peng, Cong, et al.
Publicado: (2015)

Activation of immediate-early response gene c-Fos protein in the rat paralimbic cortices after myocardial infarction
por: Ahn, Ji Yun, et al.
Publicado: (2015)

FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells
por: An, Hyun-Jung, et al.
Publicado: (2022)

Expression of focal adhesion kinase, Akt/PKB, Elk-1 and p90RSK in rheumatoid arthritis tissues but not at sites of cartilage invasion
por: Seemayer, CA, et al.
Publicado: (2003)

Fibroblast and Epidermal Growth Factors Utilize Different Signaling Pathways to Induce Anchorage-independent Cell Transformation in JB6 Cl41 Mouse Skin Epidermal Cells
por: Lee, Cheol-Jung, et al.
Publicado: (2014)

A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer
por: Arul, Narayanasamy, et al.
Publicado: (2013)

SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma
por: Lee, Hye Seung, et al.
Publicado: (2016)

Spent Mushroom Substrate Influences Elk (Cervus Elaphus Canadensis) Hematological and Serum Biochemical Parameters
por: Park, Jae Hong, et al.
Publicado: (2012)

RSK2 and ERα comrades-in-arms in homeostasis and transformation
por: Ludwik, Katarzyna A., et al.
Publicado: (2020)

Gastrodia elata Blume alleviates L-DOPA-induced dyskinesia by normalizing FosB and ERK activation in a 6-OHDA-lesioned Parkinson’s disease mouse model
por: Doo, Ah-Reum, et al.
Publicado: (2014)

Luteolin suppresses UVB-induced photoageing by targeting JNK1 and p90(RSK2)
por: Lim, Sung H, et al.
Publicado: (2013)

Dihydrocapsaicin Inhibits Epithelial Cell Transformation through Targeting Amino Acid Signaling and c-Fos Expression
por: Lee, Ji Su, et al.
Publicado: (2019)

Recruitment and Activation of RSK2 by HIV-1 Tat
por: Hetzer, Claudia, et al.
Publicado: (2007)

RSK1 activation promotes invasion in nodular melanoma
por: Salhi, Amel, et al.
Publicado: (2015)

The incidence and etiology of sixth cranial nerve palsy in Koreans: A 10-year nationwide cohort study
por: Jung, Eun Hye, et al.
Publicado: (2019)

Stat2 stability regulation: an intersection between immunity and carcinogenesis
por: Lee, Cheol-Jung, et al.
Publicado: (2020)

Ginsenosides Have a Suppressive Effect on c-Fos Expression in Brain and Reduce Cardiovascular Responses Increased by Noxious Stimulation to the Rat Tooth
por: Jung, Ji-Yeon, et al.
Publicado: (2013)

FMK, an Inhibitor of p90RSK, Inhibits High Glucose-Induced TXNIP Expression via Regulation of ChREBP in Pancreatic β Cells
por: Han, Jung-Hwa, et al.
Publicado: (2019)

Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima
por: Hwang, Ae-Rang, et al.
Publicado: (2023)

Quetiapine and aripiprazole signal differently to ERK, p90RSK and c-Fos in mouse frontal cortex and striatum: role of the EGF receptor
por: Pereira, Avril, et al.
Publicado: (2014)

Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity
por: Koizumi, Yukio, et al.
Publicado: (2018)

Activation of RSK by phosphomimetic substitution in the activation loop is prevented by structural constraints
por: Somale, Desiana, et al.
Publicado: (2020)

Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)
por: Chen, Hanyong, et al.
Publicado: (2015)

ELK3 Suppresses Angiogenesis by Inhibiting the Transcriptional Activity of ETS-1 on MT1-MMP
por: Heo, Sun-Hee, et al.
Publicado: (2014)

RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases
por: Shi, Geng-Xian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_he12uokh1ek0h9kstclnil24j4